Skip to main content
. 2020 Sep 18;106(4):678–697. doi: 10.1016/j.jhin.2020.09.022

Table V.

Frequency and magnitude of SARS-CoV-2 viral RNA load in stool or rectal swab samples obtained from COVID-19 patients

Number of COVID 19 patients Gastrointestinal symptoms Viral RNA in stool or rectal swab samples Viral RNA load Additional information Reference
59 15 with symptoms (25.4%) 9 patients (15.3%) 4.7 log10 cpm 5.1 log10 cpm in patients with diarrhoea, 3.9 log10 cpm in patients without diarrhoea [209]
44 without symptoms (74.6%) 4 patients (9.1%)
5 1 with symptoms (20%) 2 patients (40%) 6.2–8.1 log10 cpg Detection on days 2–19 [11]
4 without symptoms (80%)
15 Not described for the subgroup 4 patients (26.7%) Not described None [15]
15 Not described Number of patients not described 3.6 log10 cpm None [152]
17 Not described 9 patients (52.9%) 2.7–5.1 log10 cpm None [13]
4 Not described 4 patients (100%) 3–8 log10 cps Virus isolation from stool samples was unsuccessful, irrespective of viral RNA concentration [7]
46 16 with symptoms (35%), 30 without symptoms (65%) 2 patients (4%) Ct values 29.9 None [116]
38 Not described 8 patients (21%) 6.5 log10 cpm Mean; virus isolation from stool samples was unsuccessful [117]
28 Not described 12 patients (42.9%) 2.8–3.5 log10 PFU equivalent per mL Virus isolation in 2 out of 3 patients successful [118]
12 Not described 11 patients (92%) 4.1–10.3 log10 cpm Children; median RNA load in fecal samples significantly higher than for nasopharyngeal swab specimens [119]

cpg, copies per g; cpm, copies per mL; cps, copies per whole swab; PFU, plaque-forming units.